Albina Minlikeeva
PhD
Clinical Assistant Professor
Research Topics
Ovarian cancer risk and prognosis; modifiable and unmodifiable risk factors
Selected Publications
- Minlikeeva AN, Moysich KB. An aspirin a day keeps ovarian cancer at bay? Expert Rev Anticancer Ther. 2019 Jul; 19(7): 541-542 Epub 2019 Jun5.
- Aili Zhou, Albina N Minlikeeva, Sadat Khan, Kirsten B. Moysich. Association between Cigarette Smoking and Histotype-Specific Epithelial Ovarian Cancer: A Review of Epidemiologic Studies. Cancer Epidemiology, Biomarkers & Prevention 2019 Jul;28(7):1103-1116.
- Albina N. Minlikeeva, Rikki A. Cannioto¸ Allan Jensen, Suzanne K. Kjaer, Francesmary Modugno, Hani Almohanna, J. Brian Szender, Paul Mayor, Kirsten Starbuck, Kunle Odunsi, Anna DeFazio on behalf of the Australian Ovarian Cancer Study Group, Susan J. Jordan, Harvey A. Risch, Mary Anne Rossing, Jennifer A. Doherty, Marc T. Goodman, Robert Edwards, Roberta B. Ness, Keitary Matsuo, Mika Mizuno, Ellen L.Goode, Estrid Hogdall, Kathryn L. Terry, Daniel W. Cramer, Elisa V. Bandera, Lisa E. Paddock, Celeste L. Pearce, Anna H. Wu, Penelope M. Webb, and Kirsten B. Moysich on behalf of the Ovarian Cancer Association Consortium. Joint exposure to smoking, excessive weight, and physical inactivity affects survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes and Control. 2019 May;30(5):537-547.
- Albina N. Minlikeeva, Paul C. Mayor, John L. Etter, Rikki Cannioto, Francesmary Modugno, Roberta Ness, Kristen Starbuck, Robert P. Edwards, Brahm H. Segal, Sashikant Lele, Kunle Odunsi, Brenda Diergaarde, Kirsten B. Moysich. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes Control. 2018 Feb;29(2):201-212
- Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, Jordan SJ, Fasching PA, Beckmann MW, Risch HA, Rossing MA, Doherty JA, Chang-Claude J, Goodman MT, Dörk T, Edwards R, Modugno F, Ness RB, Matsuo K, Mizuno M, Karlan BY, Goode EL, Kjær SK, Høgdall E, Schildkraut JM, Terry KL, Cramer DW, Bandera EV, Paddock LE, Kiemeney LA, Massuger LFAG, Sutphen R, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Kupryjanczyk J, Jensen A, Webb PM, Moysich KB; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1470-1473.
- Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, Hillemanns P, Høgdall E, Jensen A, Jordan SJ, Karlan BY, Kjær SK, Klapdor R, Matsuo K, Mizuno M, Nagle CM, Odunsi K, Paddock L, Rossing MA, Schildkraut JM, Schmalfeldt B, Segal BH, Starbuck K, Terry KL, Webb PM, Zsiros E, Ness RB, Modugno F, Bandera EV, Chang-Claude J, Moysich KB. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. Br J Cancer. 2017 Sep 26;117(7):1063-1069. Epub 2017 Aug 17.